Tecan Group AG - Asset Resilience Ratio
Tecan Group AG (TECN) has an Asset Resilience Ratio of 20.48% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tecan Group AG current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Tecan Group AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Tecan Group AG (TECN) total assets.
Liquid Assets Composition Over Time
This chart breaks down Tecan Group AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Tecan Group AG's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF255.66 Million | 13.19% |
| Short-term Investments | CHF141.34 Million | 7.29% |
| Total Liquid Assets | CHF397.00 Million | 20.48% |
Asset Resilience Insights
- Good Liquidity Position: Tecan Group AG maintains a healthy 20.48% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Tecan Group AG Industry Peers by Asset Resilience Ratio
Compare Tecan Group AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Amplitude Surgical SAS
PA:AMPLI |
Medical Instruments & Supplies | 0.71% |
|
Suzhou Iron Technology Co. Ltd. A
SHG:688329 |
Medical Instruments & Supplies | 0.36% |
|
DIO Corporation
KQ:039840 |
Medical Instruments & Supplies | 8.52% |
Annual Asset Resilience Ratio for Tecan Group AG (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Tecan Group AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 19.14% | CHF406.01 Million ≈ $513.30 Million |
CHF2.12 Billion ≈ $2.68 Billion |
+1.47pp |
| 2023-12-31 | 17.67% | CHF366.42 Million ≈ $463.26 Million |
CHF2.07 Billion ≈ $2.62 Billion |
+4.09pp |
| 2022-12-31 | 13.57% | CHF293.24 Million ≈ $370.73 Million |
CHF2.16 Billion ≈ $2.73 Billion |
+1.74pp |
| 2021-12-31 | 11.84% | CHF241.91 Million ≈ $305.84 Million |
CHF2.04 Billion ≈ $2.58 Billion |
-29.82pp |
| 2020-12-31 | 41.65% | CHF470.92 Million ≈ $595.37 Million |
CHF1.13 Billion ≈ $1.43 Billion |
+36.28pp |
| 2019-12-31 | 5.37% | CHF50.50 Million ≈ $63.85 Million |
CHF939.77 Million ≈ $1.19 Billion |
+5.26pp |
| 2018-12-31 | 0.11% | CHF977.00K ≈ $1.24 Million |
CHF857.67 Million ≈ $1.08 Billion |
-0.01pp |
| 2017-12-31 | 0.13% | CHF1.02 Million ≈ $1.29 Million |
CHF803.96 Million ≈ $1.02 Billion |
-33.80pp |
| 2016-12-31 | 33.93% | CHF249.78 Million ≈ $315.79 Million |
CHF736.16 Million ≈ $930.71 Million |
+33.73pp |
| 2015-12-31 | 0.20% | CHF1.27 Million ≈ $1.60 Million |
CHF641.48 Million ≈ $811.01 Million |
-0.13pp |
| 2014-12-31 | 0.33% | CHF1.82 Million ≈ $2.31 Million |
CHF552.26 Million ≈ $698.21 Million |
-- |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, … Read more